Yuequan Bionics Secures Hundreds of Millions in Pre-A+ Round, Bionic Hand Mass-Produced
Decision Brief
What changedYuequan Bionics has completed a significant Pre-A+ financing round, and its bionic tension-compression dexterous hand Y-Hand M1 has reached mass production with orders exceeding 100 million RMB.
Why it mattersTheir bionic tension-compression technology solves the trade-off between performance, cost, and reliability in rigid dexterous hands, offering a scalable flexible manipulation solution for humanoid robot developers.
Who should careAll AI builders
Affected stackNo specific stack identified
Source confidenceMedium · Reliable media or first-hand reporting
Yuequan Bionics recently closed a Pre-A+ funding round worth hundreds of millions RMB, led by Changfa Fund and Huakong Fund, with existing investors participating. The funds will support team expansion, R&D, and production capacity. Based on bionic tension-compression robot theory, the company has launched four product lines: Y-Hand series (M1 lightweight: 299.7g, 26 DOF, 200N grip; M2 flagship: 38 DOF), X-Hand M1 rigid hand (50kg load, million-cycle life), YQ Motors (4-22mm custom sizes), and Bowen W-Bot 2.0 wheeled humanoid. The dexterous hand has already been mass-produced with over 10,000 units and cumulative orders exceeding 100 million RMB.
Summary basis: full article readCompiled from the source scope noted above; the original remains authoritative.
Sources
- 36氪
Chinese tech/startup coverage; AI signal filtered from broader business news.
- 36氪
留言
登入后即可留言，和其他 builder 交换实测心得。
还没有留言，抢头香。